Talazoparib and Thoracic RT for ES-SCLC

Clinical trial NCT04170946 · RECRUITING

Trial details

NCT number: NCT04170946
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Small-Cell Lung Cancer

Start date: 2020-10-05
Primary completion: 2027-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.